Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review)
One of the main problems of nasopharyngeal carcinoma treatment is the high incidence regional and distant failures. The method of choice in the first line therapy for the primarily diagnosed nasopharyngeal carcinoma is chemoradiotherapy with poor success rate. The main etiological factor in the occu...
Saved in:
| Main Authors: | D. A. Miroshnichenko, A. P. Polyakov, A. V. Mordovsky |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2020-11-01
|
| Series: | Опухоли головы и шеи |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/564 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRISPR/Cas13-Mediated Inhibition of EBNA1 for Suppression of Epstein–Barr Virus Transcripts and DNA Load in Nasopharyngeal Carcinoma Cells
by: Lin Lin, et al.
Published: (2025-06-01) -
Early diagnosis and personalized comprehensive treatment of nasopharyngeal carcinoma based on Epstein-Barr virus-specific markers
by: CHEN Jie, et al.
Published: (2024-09-01) -
Diagnostic significance of DNA and antibodies against capsid antigens of anti-Epstein–Barr virus antibodies levels in blood plasma of nasopharyngeal carcinoma patients from non-endemic region
by: V. E. Gurtsevich, et al.
Published: (2015-06-01) -
Markers of Epstein–Barr virus in clinical assessment of Russian patients with nasopharyngeal cancer
by: K. V. Smirnova, et al.
Published: (2021-11-01) -
Epstein–Barr virus and mechanisms of molecular carcinogenesis
by: A. D. Molchanov, et al.
Published: (2025-06-01)